Amedisys (AMED) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys (AMED) Tops Q3 EPS by 1c

Piper Jaffray Raises Price Target as Amedisys (AMED) Raises Acquisition Pipeline

November 6, 2015 11:44 AM EST

Piper Jaffray reiterated a Neutral rating on Amedisys (NASDAQ: AMED), and raised the price target to $45.00 (from $42.00), following the company's 3Q report. AMED's acquisition pipeline has increased from 17 potential targets a year ago to over 300. While deal valuations have increased to... More